Skip to main content
. 2016 Dec 8;129(5):192–200. doi: 10.1007/s00508-016-1143-1

Fig. 5.

Fig. 5

Initial diabetes therapy (Met metformin, DPP-4i dipeptidyl peptidase-4 inhibitor, DPP-4i + Met dipeptidyl peptidase-4 inhibitor + metformin, GLP-1 glucagon-like peptide-1 receptor agonists)